[Congressional Record Volume 146, Number 73 (Tuesday, June 13, 2000)]
[Daily Digest]
[Pages D583-D585]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

Committee Meetings
(Committees not listed did not meet)
APPROPRIATIONS--TRANSPORTATION
Committee on Appropriations: Committee ordered favorably reported an 
original bill, making appropriations for the Department of 
Transportation and related

[[Page D584]]

agencies for the fiscal year ending September 30, 2001.
APPROPRIATION--DISTRICT OF COLUMBIA
Committee on Appropriations: Subcommittee on District of Columbia 
concluded hearings on proposed budget estimates for fiscal year 2001 
for the District of Columbia, after receiving testimony from Mayor 
Anthony A. Williams, Linda W. Cropp, Chairman, Council of the District 
of Columbia, and Alice M. Rivlin, Chairman, District of Columbia 
Financial Responsibility and Management Assistance Authority, all of 
Washington, D.C.
APPROPRIATIONS--TRANSPORTATION
Committee on Appropriations: Subcommittee on Transportation approved 
for full committee consideration an original bill, making 
appropriations for the Department of Transportation and related 
agencies for the fiscal year ending September 30, 2001.
MERCHANT BANKING ACTIVITIES
Committee on Banking, Housing, and Urban Affairs: Subcommittee on 
Financial Institutions and Subcommittee on Securities concluded joint 
hearings to examine the regulation of merchant banking activities under 
the Gramm-Leach-Bliley Act of 1999, after receiving testimony from Gary 
Gensler, Under Secretary of the Treasury for Domestic Finance; Lawrence 
H. Meyer, Member, Board of Governors, Federal Reserve System; Frederick 
M. Fritz, BancBoston Capital, Boston, Massachusetts, and Jeffrey 
Walker, Chase Capital Partners, New York, New York, both on behalf of 
the Financial Services Roundtable; Marc E. Lackritz, Securities 
Industry Association, and Joseph S. Bracewell, Century National Bank, 
on behalf of the Independent Community Bankers of America, both of 
Washington, D.C.; and John P. Whaley, Norwest Equity Partners and 
Norwest Venture Partners, Minneapolis, Minnesota, on behalf of the 
American Bankers Association and American Bankers Association 
Securities Association.
ONLINE PROFILING AND PRIVACY
Committee on Commerce, Science, and Transportation: Committee concluded 
hearings to examine online profiling done by Internet network 
advertisers and how it impacts consumer's privacy, after receiving 
testimony from Jodie Bernstein, Director, Bureau of Consumer 
Protection, and David Medine, Associate Director for Financial 
Practices, both of the Federal Trade Commission; Jules Polonetsky, 
DoubleClick, New York, New York; Daniel Jaye, Engage, Inc., Andover, 
Massachusetts; Marc Rotenberg, Electronic Privacy Information Center, 
Washington, D.C.; and Richard M. Smith, Brookline, Massachusetts.
NOMINATIONS
Committee on Environment and Public Works: Committee concluded hearings 
on the nominations of James V. Aidala, of Virginia, to be Assistant 
Administrator for Toxic Substances of the Environmental Protection 
Agency, Arthur C. Campbell, of Tennessee, to be Assistant Secretary of 
Commerce for Economic Development, and Ella Wong-Rusinko, of Virginia, 
to be Alternate Federal Co-chairman of the Appalachian Regional 
Commission, after the nominees testified and answered questions in 
their own behalf. Mr. Aidala was introduced by Senators Lieberman and 
Roberts, Mr. Campbell was introduced by Senator Frist and 
Representatives Bennie Thompson and Wamp, and Ms. Wong-Rusinko was 
introduced by Senators Warner and Hutchison.
TIBET
Committee on Foreign Relations: Subcommittee on East Asian and Pacific 
Affairs concluded hearings to examine recent developments in promoting 
a positive Tibetan/Chinese relationship, while sustaining Tibet's 
unique religious, linguistic, and cultural heritage, after receiving 
testimony from Julia V. Taft, Special Coordinator for Tibet, Department 
of State; John Ackerly, International Campaign for Tibet, Washington, 
D.C.; Elliot Spurling, Indiana University Department of Central 
Eurasian Studies, Bloomington, on behalf of the Human Rights Watch; and 
Elizabeth Napper, Tibetan Nuns' Project, San Geronimo, California.
POST-CONVICTION DNA TESTING
Committee on the Judiciary: Committee concluded hearings on post-
conviction DNA testing, focusing on how to incorporate DNA testing more 
fully into the American criminal justice system, and related proposals, 
after receiving testimony from Oklahoma Attorney General W.A. Drew 
Edmondson, Oklahoma City; New York State Attorney General Eliot 
Spitzer, New York; California Deputy Attorney General Enid A. Camps, 
Sacramento; Charles F. Baird, former Judge, Texas Court of Criminal 
Appeals, Austin, on behalf of the National Committee to Prevent 
Wrongful Executions; Joshua K. Marquis, Clatsop County District 
Attorney, Astoria, Oregon, on behalf of the National District 
Attorney's Association; Barry C. Scheck, Benjamin N. Cardozo School of 
Law, New York, New York, on behalf of the Innocence Project, George 
Clarke, San Diego County Deputy District Attorney, California, and 
James Wooley, Baker and Hostetler, Case Western Reserve University Law 
School, Washington, D.C., all on behalf of the National Commission on 
the Future of DNA Testing; Bryan A. Stevenson, New York University 
School of Law, New York, on behalf

[[Page D585]]

of the Equal Justice Initiative of Alabama; and Dennis Fritz, Kansas 
City, Missouri.
PRESCRIPTION DRUG SAFETY AND PRICING
Committee on Health, Education, Labor, and Pensions: Committee 
concluded hearings to examine the accessibility of affordable 
prescription drugs, the price differentials for identical prescription 
drugs in the international marketplace, and drug quality and safety, 
after receiving testimony from Senators Gorton, Dorgan, Johnson, and 
Burns; Representative Sanders; Christopher T. Rhodes, University of 
Rhode Island, Kingston; Patricia M. Danzon, University of Pennsylvania 
Wharton School of Management, Philadelphia; Stephen W. Schondelmeyer, 
University of Minnesota College of Pharmacy PRIME Institute, 
Minneapolis; Ronald F. Pollack, Families USA, and Alan F. Holmer, 
Pharmaceutical Research and Manufacturers of America, both of 
Washington, D.C.; and Paul Abrams, NeoRx Corporation, Seattle, 
Washington, on behalf of the Biotechnology Industry Organization.